Aier Eye Hospital Group Co., Ltd. Stock

Equities

300015

CNE100000GR6

Healthcare Facilities & Services

End-of-day quote Shenzhen S.E. 06:00:00 2024-04-24 pm EDT 5-day change 1st Jan Change
12.24 CNY +2.34% Intraday chart for Aier Eye Hospital Group Co., Ltd. -1.45% -22.63%
Sales 2024 * 25.24B 3.48B Sales 2025 * 30.35B 4.19B Capitalization 114B 15.76B
Net income 2024 * 4.32B 597M Net income 2025 * 5.42B 748M EV / Sales 2024 * 4.2 x
Net cash position 2024 * 8.04B 1.11B Net cash position 2025 * 10.24B 1.41B EV / Sales 2025 * 3.42 x
P/E ratio 2024 *
26.3 x
P/E ratio 2025 *
20.9 x
Employees 32,326
Yield 2024 *
1.35%
Yield 2025 *
1.72%
Free-Float 23.87%
More Fundamentals * Assessed data
Dynamic Chart
Nomura Adjusts Aier Eye Hospital's Price Target to 15.35 Yuan From 22.14 Yuan, Keeps at Buy MT
Hepalink Pharmaceutical Gets Lifeline from Controlling Shareholder MT
Nomura Adjusts Aier Eye Hospital Group’s Price Target to 22.14 Yuan From 25.03 Yuan, Keeps at Buy. MT
Tranche Update on Aier Eye Hospital Group Co., Ltd.'s Equity Buyback Plan announced on October 26, 2023. CI
Aier Eye Hospital Group Co., Ltd. agreed to acquire a 65.1% stake in Taishan Aier New Hope Hospital Co., Ltd. from Nanjing Aier Anxing Ophthalmic Medical Industry Investment Center (Limited Partnership) for CNY 32.56 million CI
Aier Eye Hospital Group Co., Ltd. agreed to acquire a 72% stake in Tangshan Aier Eye Hospital Co., Ltd. from Nanjing Aier Anxing Ophthalmic Medical Industry Investment Center (Limited Partnership) for CNY 72 million CI
Aier Eye Hospital Group Co., Ltd. agreed to acquire a 51% stake in Xianyang Aier Eye Hospital Co., Ltd. from Nanjing Aier Anxing Ophthalmic Medical Industry Investment Center (Limited Partnership) for CNY 30.6 million CI
Aier Eye Hospital Group Co., Ltd. agreed to acquire an additional 51% stake in Hengdong Aier Eye Hospital Co., Ltd. from Nanjing Aier Anxing Ophthalmic Medical Industry Investment Center (Limited Partnership) for CNY 16.94 million CI
Aier Eye Hospital Group Co., Ltd. agreed to acquire 69.941% stake in Suining Aier Eye Hospital Co., Ltd. from Hunan Liangshi Chenxing Medical Industry Management Partnership Enterprise (Limited Partnership) for 36.4 million. CI
Aier Eye Hospital Group Co., Ltd. agreed to acquire 71.8002% stake in Beiliu Aier Eye Hospital Co., Ltd. from Hunan Liangshi Chenxing Medical Industry Management Partnership Enterprise (Limited Partnership) for 21.5 million. CI
Aier Eye Hospital Group Co., Ltd. announces an Equity Buyback for CNY 300 million worth of its shares. CI
Tranche Update on Aier Eye Hospital Group Co., Ltd.'s Equity Buyback Plan announced on May 29, 2023. CI
Aier Eye Hospital Group Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2023 CI
Aier Eye Hospital Group Co., Ltd. authorizes a Buyback Plan. CI
Aier Eye Hospital Group Co., Ltd.'s Equity Buyback announced on May 29, 2023 has closed with 18,564,521 shares, representing 0.2% for CNY 366.36 million. CI
More news
1 day+2.34%
1 week-1.45%
Current month-4.38%
1 month-6.06%
3 months-12.26%
6 months-26.31%
Current year-22.63%
More quotes
1 week
11.80
Extreme 11.8
12.40
1 month
11.80
Extreme 11.8
13.20
Current year
11.80
Extreme 11.8
15.91
1 year
11.80
Extreme 11.8
23.27
3 years
11.80
Extreme 11.8
42.79
5 years
9.05
Extreme 9.0467
42.79
10 years
1.63
Extreme 1.6279
42.79
More quotes
Managers TitleAgeSince
Founder 59 03-01-23
Chairman 46 -
Director of Finance/CFO 62 12-01-05
Members of the board TitleAgeSince
Founder 59 03-01-23
Director/Board Member 67 19-11-27
Founder 59 03-01-23
More insiders
Date Price Change Volume
24-04-26 12.63 +3.19% 127,806,300
24-04-25 12.24 +2.34% 98,012,330
24-04-24 11.96 -0.99% 59,724,480
24-04-23 12.08 +0.83% 77,429,720
24-04-22 11.98 -1.32% 84,244,940

End-of-day quote Shenzhen S.E., April 24, 2024

More quotes
AIER Eye Hospital Group Co., Ltd. specializes in the ownership and operation of eye care facilities. The group provides diagnostic services, medical optometry and surgical services (refractive corneal surgery, cataract surgery, etc.).
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
B+
More Ratings
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
20
Last Close Price
12.24 CNY
Average target price
23.26 CNY
Spread / Average Target
+90.04%
Consensus
  1. Stock Market
  2. Equities
  3. 300015 Stock